钱小军

Shape86Shape85Shape84Shape83Shape82Shape81Shape80Shape79Shape78Shape77Shape76Shape75Shape74Shape73Shape72Shape71Shape70Shape69Shape68Shape67Shape66Shape65Shape64Shape63Shape62Shape61Shape60Shape59Shape58Shape57Shape56Shape55Shape54Shape53Shape52Shape51Shape50Shape49Shape48Shape47Shape46Shape45Shape44Shape43Shape42Shape41Shape40Shape39Shape38Shape37Shape36Shape35Shape34Shape33Shape32Shape31Shape30Shape29Shape28Shape27Shape26Shape25Shape24Shape23Shape22Shape21Shape20Shape19Shape18Shape17Shape16Shape15Shape14Shape13Shape12Shape11Shape10Shape9Shape8Shape7Shape6Shape5Shape4Shape3Shape2Shape1





  • 研究组主要研究兴趣及方向:

1.肿瘤免疫微环境

2.肿瘤营养与代谢

3.肿瘤信号传导与耐药


  • 个人简况:

  1. 导师类型:科学学位硕士生导师

  2. 专业技术职称:副主任医师

  3. 行政职务:无

  4. 招生专业:肿瘤学

  5. 简介:

1986年5月出生。

①学术任职情况:

安徽省癌症研究会肿瘤代谢委员会副主委

中国医师协会肿瘤医师分会胃癌学组委员

中国胸部肿瘤研究协作组‌青年专家委员会(CTONG YONG)成员

安徽省医学会肿瘤内科学分会委员

安徽省医学会青委会委员

安徽省医学会肠外肠内营养学分会委员

安徽省癌症研究会食管癌专业委员会委员

②个人教育及工作经历:

(1) 2003/09-2008/06,安徽医科大学,附属省立医院,学士

(2) 2008/09-2010/06,安徽医科大学,附属省立医院,硕士,导师:胡冰

(3) 2010/07-2011/08,中国科学技术大学附属第一医院,肿瘤科,住院医师

(4) 2011/09-2014/06,中山大学,肿瘤防治中心,博士,导师:朱孝峰

(5) 2014-07至2015-12,中国科学技术大学附属第一医院,肿瘤科,住院医师

(6) 2016-01至2021-12,中国科学技术大学附属第一医院,肿瘤科,主治医师

(7) 2022-01至今,中国科学技术大学附属第一医院,肿瘤科,副主任医师

(8) 2019-10至2023-10,中科大附属第一医院,生物学,博士后,导师:周荣斌、潘跃银

(9) 2022-01至今,中国科学技术大学附属第一医院,肿瘤科,副主任医师



  • 联系方式:

E-mail: qianxj@ustc.edu.cn

电话:15956970125


  • 近五年发表重要学术论文:

示例:(1) Haiyang Yu#, Xin Sun#, Yan Li, Jing Pan, Xuemei Liu, Hongbin He, Haibo Wu*, Yubei Sun*, Yueyin Pan*,Xiaojun Qian*. Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity,J Immunother Cancer. 2025 Oct 5;13(10):e012182

(2) Yueli Xu#; Jiaxian Yan#; Ye Tao; Xiaojun Qian; Chi Zhang; Libei Yin; Pengying Gu; Yehai Liu; Yueyin Pan; Renhong Tang*; Wei Jiang*; Rongbin Zhou*; Pituitary hormone α-MSH promotes tumorinduced myelopoiesis and immunosuppression, Science, 2022; 377(6610): 1085-1091

(3) Wu Y#, Pan J#, Wei J#, Wang Z, Chen Q, Li M,Qian X*, Pan Y*, Yu H*. Elevated FBXL6 activates ATAD3A through K63-linked polyubiquitination and promotes the malignant progression of TNBC via metabolic reprogramming. Int J Biol Macromol. 2025 Nov;329(Pt 2):147713.

(4) Yan Yu#; Xiao-Dan Peng#; Xiao-Jun Qian#; Kai-Ming Zhang#; Xiang Huang; Yu-Hong Chen; Yun-Tian Li; Gong-Kan Feng; Hai-Liang Zhang; Xue-Lian Xu; Shun Li; Xuan Li; Jia Mai; Zhi-Ling Li; Yun Huang; Dong Yang; Li-Huan Zhou; Zhuo-Yan Zhong; Jun-Dong Li, Rong Deng*; Xiao-Feng Zhu*. Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis, Signal Transduct Target Ther. 2021 Dec 1;6(1):401.

(5) Xiaojun Qian#; Ronghua Shi#; Jian Chen; Yong Wang; Xinghua Han; Yubei Sun; Cong Ling; Gang Wang*; An-Wu Xu*; Yueyin Pan*; The single-atom iron nanozyme mimicking peroxidase remodels energy metabolism and tumor immune landscape for synergistic chemodynamic therapy and photothermal therapy of triple-negative breast cancer. Front Bioeng Biotech. 2022 Oct 26; 10:1026761.

(6) Xiaojun Qian#, Wei Jia#, Yuntian Li, Jian Chen, Jinguo Zhang* and Yubei Sun*; COL4A1 Promotes Gastric Cancer Progression by Regulating Tumor Invasion, Tumor Microenvironment and Drug Sensitivity, Curr Med Chem. 2026;33(11):2190-2210.

(7) Jian chen*; Yuntian Li; Xinghua Han; Yueyin Pan; Xiaojun Qian*; An autophagic gene-based signature to predict the survival of patients with low-grade gliomas. Cancer Med. 2021 Mar;10(5):1848-1859.

(8) Haiyang Yu#, Qinhao Chen#, Ziming Wang,Xiaojun Qian*and Yueyin Pan*; Pan-cancer and single-cell analysis reveals FAM83D expression as a cancer prognostic biomarker, Front Genet. 2022 Dec 9; 13:1009325.


  • 本人承担在研科研项目:(仅限于主要负责人)

项目名称、来源

起止时间

总经费(万元)

POMC神经元来源α-MSH通过骨骼肌MC5R调控线粒体裂变诱导肿瘤恶液质的机制研究,国家自然科学基金面上项目

2027/01-2030/12

49

统筹推进世界一流大学和一流学科建设专项资金资助,重要方向, YD9110002052,阿替丽珠单抗联合化疗序贯阿替丽珠单抗联合安罗替尼治疗小细胞肺癌的有效性和疗效差异的机制探索,“科大新医学”重要方向

2024/01- 2026/12

80



  • 本人成果获奖情况

获奖名称

颁奖部门

获奖等级

本人排名

获奖时间

中国科学技术大学附属第一医院(安徽省立医院)第三届第二批杰出中青年人才

安徽省立医院


1

2023-11